This study is completed in the United States, in Romania, in Russia, .... It is testing cariprazine for schizophrenia.
SchizophreniaDrugFrom 18 Years to 60 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether the Safety and Efficacy of Cariprazine may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive the Safety and Efficacy of Cariprazine, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Romania, in Russia, and in Ukraine.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
State Healthcare Institution <Arkhangelsk Regional Clinical Psychiatric Hospital>
Arkhangelsk
Site status: Not listed — confirm with the team
State Healthcare Institution "Regional Clinical Specialized Psychoneurological Hospital #1"
Chelyabinsk
Site status: Not listed — confirm with the team
State Educational Institution of High Professional Education "Chita State Medical Academy of Roszdrav"
Chita
Site status: Not listed — confirm with the team
St. Petersburg State Healthcare Institution "Mental Hospital #1 named after P.P Kashchenko"
Gatchina
Site status: Not listed — confirm with the team
St. Petersburg State Healthcare Institution "St. Nicholas the Wonderworker Mental Hospital"
Saint Petersburg
Site status: Not listed — confirm with the team
Federal State Budget Institution "St. Petersburg scientific-research psychoneurological Institute named after V.M Bekhterev" of the Ministry of Health and Social Development of the Russian Federation, Department of biological therapy of mental patients
Saint Petersburg
Site status: Not listed — confirm with the team
State institution "St. Petersburg scientifis-research psychoneurologic Institute of RosZdrav named after V.M Bekhterev"
Saint Petersburg
Site status: Not listed — confirm with the team
Federal State Budget Institution "St. Petersburg scientific-research psychoneurological Institute named after V.M Bekhterev" of the Minitstry of Health and Social Development of the Russian Federation
Saint Petersburg
Site status: Not listed — confirm with the team
St. Petersburg State Healthcare Institution "City Mental Hospital #6 (hospital and Dispensary)"
Saint Petersburg
Site status: Not listed — confirm with the team
St. Petersburg State Healthcare Institution "City Mental Hospital #3 named after I.I Skvortsov-Stepanov", department #7
Saint Petersburg
Site status: Not listed — confirm with the team
Municipal Healthcare Institution "City Clinical Hospital #2 named after V.I Razumovsky"
Saratov
Site status: Not listed — confirm with the team
State Healthcare Institution "Saratov Saint Sophia Regional Mental Hospital"
Saratov
Site status: Not listed — confirm with the team
Regional State Healthcare Institution "Tomsk Clinical Mental Hospital"
Tomsk
Site status: Not listed — confirm with the team
Ukraine · 12 sites
Communal Institution of Kyiv Regional Council: Regional Psychiatric-Narcological Medical Association, Department #2 and #14
Village Glevakha, Kyiv Oblast
Site status: Not listed — confirm with the team
I.I. Mecnikov Regional Clinical Hospital, Regional Center of Psychosomatic Pathology
Dnipropetrovsk
Site status: Not listed — confirm with the team
Ukraine State Scientific and Research Institute of Medical and Social Problems of Disabiolity, Department of Psychoneurology, Psychotherapy and Medical Psychology
Dnipropetrovsk
Site status: Not listed — confirm with the team
Regional Clinical Psychiatric Hospital Department #11, M. Gorkyy Donetsk National Medical University, Chair of Psychiatry and Medical Psychology
Donetsk
Site status: Not listed — confirm with the team
Kharkiv Regional Clinical Psychiatric Hospital #3, Department #4, Department #14
Kharkiv
Site status: Not listed — confirm with the team
State Institution: Institute of Neurology, Psychiatry and Narcology of the AMS of Ukraine, Department of Borderline Psychic Pathology
Kharkiv
Site status: Not listed — confirm with the team
Kherson Regional Psychiatric Hospital, Department #3
Kherson
Site status: Not listed — confirm with the team
Kyiv City Clinical Psychoneurological Hospital #1, Center of Novel Treatment Methods and Rehabilitation of Psychotic Conditions
Kyiv
Site status: Not listed — confirm with the team
Communal Institution: Lviv Regional Clinical Psychiatric Hospital, Department #3 (male), Department #10 (female)
Lviv
Site status: Not listed — confirm with the team
O.F. Maltsev Poltava Regional Clinical Psychiatric Hopspital, Department #3B, State Institution of Higher Education of Ukraine: Ukranian Medical Stomatological Academy, Chair of Psychiatry, Narcology and Medical Psychology
Poltava
Site status: Not listed — confirm with the team
Crimean Republican Institution: Clinical Psychiatric Hospital #1, Female Psychiatric Department #2, Male Psychiatric Department #1, S.I. Georgiyevskyy Crimean State Medical University, Chair of Psychiatry, Psychotherapy and Narcology
Simferopol
Site status: Not listed — confirm with the team
O.I. Yuschenko Vinnytsya Regional Psychoneurological Hospital, Department #10, Department #14, M.I. Pyrogov Vinnytsya National Medical University, Chair of Psychiatry and Narcology
Vinnytsia
Site status: Not listed — confirm with the team
United States · 20 sites
Woodland International Research Group, Inc.
Little Rock, Arkansas
Site status: Not listed — confirm with the team
Woodland Research Northwest, LLC
Springdale, Arkansas
Site status: Not listed — confirm with the team
Synergy Clinical Research of Escondido
Escondido, California
Site status: Not listed — confirm with the team
Excell Research, Inc
Oceanside, California
Site status: Not listed — confirm with the team
Clinical Innovations, Inc.
Riverside, California
Site status: Not listed — confirm with the team
Sharp Mesa Vista Hospital
San Diego, California
Site status: Not listed — confirm with the team
Collaborative Neuroscience Network, Inc.
Torrance, California
Site status: Not listed — confirm with the team
Colorado Clinical Trials, Inc.
Littleton, Colorado
Site status: Not listed — confirm with the team
Comprehensive Clinical Development, Inc.
Washington D.C., District of Columbia
Site status: Not listed — confirm with the team
Florida Clinical Research Center, LLC
Bradenton, Florida
Site status: Not listed — confirm with the team
Hawaii Clinical Research Center
Honolulu, Hawaii
Site status: Not listed — confirm with the team
Uptown Research Institute, LLC
Chicago, Illinois
Site status: Not listed — confirm with the team
Alexian Brothers Center for Psychiatric Research
Hoffman Estates, Illinois
Site status: Not listed — confirm with the team
Precise Research Centers
Flowood, Mississippi
Site status: Not listed — confirm with the team
Millennium Psychiatric Associates, LLC
Creve Coeur, Missouri
Site status: Not listed — confirm with the team
CRI Worldwide, LLC
Willingboro, New Jersey
Site status: Not listed — confirm with the team
Windsor-Laurelwood Center for Behavioral Medicine
Willoughby, Ohio
Site status: Not listed — confirm with the team
Vanderbilt Psychiatric Hospital
Nashville, Tennessee
Site status: Not listed — confirm with the team
Claghorn-Lesem Research Clinic, Ltd.
Houston, Texas
Site status: Not listed — confirm with the team
Pacific Institute of Medical Sciences
Bothell, Washington
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Cariprazine, Aripiprazole, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 60 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Forest Laboratories, which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This study is completed. It focuses on schizophrenia and currently lists study information in Argentina, Egypt, Estonia, France, Greece, Jordan, Latvia, Lebanon, Lithuania, Romania, Slovakia, South Africa, Spain, and Turkey.
